Same Indication

Dabigatran vs Montelukast

## Dabigatran vs Montelukast: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Montelukast**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Montelukast — 586.1800 g/mol.

**Type**: Dabigatran — Small molecule; Montelukast — Small molecule.